2021
Prostate Cancer Screening and Incidence among Aging Persons Living with HIV
Leapman MS, Stone K, Wadia R, Park LS, Gibert CL, Goetz MB, Bedimo R, Rodriguez-Barradas M, Shebl F, Justice AC, Brown ST, Crothers K, Sigel KM. Prostate Cancer Screening and Incidence among Aging Persons Living with HIV. Journal Of Urology 2021, 207: 324-332. PMID: 34555924, PMCID: PMC8741750, DOI: 10.1097/ju.0000000000002249.Peer-Reviewed Original ResearchConceptsPSA testingHIV statusProstate cancerProstate biopsyCancer incidenceHuman immunodeficiency virus statusProstate-specific antigen (PSA) testingVeterans Aging Cohort StudyProspective national cohortMultivariable Poisson modelsAging Cohort StudySpecific antigen testingHuman immunodeficiency virusProstate cancer screeningUninfected comparatorsCohort studyIncident cancerAntigen testingImmunodeficiency virusMean ageCancer screeningNational cohortCancer stageVirus statusMultivariable model
2020
Model selection applied to 750 outpatient ICD-9 codes identifies hazards important for all-cause cancer mortality in 2 million veterans with 14 years of follow-up.
McMahon B, Dhaubhadel S, Hengartner N, Danciu I, Janet T, Justice A. Model selection applied to 750 outpatient ICD-9 codes identifies hazards important for all-cause cancer mortality in 2 million veterans with 14 years of follow-up. Journal Of Clinical Oncology 2020, 38: 2053-2053. DOI: 10.1200/jco.2020.38.15_suppl.2053.Peer-Reviewed Original ResearchMedical recordsCause cancer mortalityVeterans' medical recordsChronic airway obstructionCongestive heart failureColon cancer screeningTobacco use disorderPrevalent codesAirway obstructionHeart failureCancer mortalityC-statisticCancer screeningCommon cancerICD9 codesUse disordersSubsequent mortalityClinical practiceColon cancerICD codesMortalityCancer treatmentVeterans AdministrationCancerAdministration
2018
Benefits and harms of lung cancer screening in HIV-infected individuals with CD4+ cell count at least 500 cells/&mgr;l
Kong CY, Sigel K, Criss SD, Sheehan DF, Triplette M, Silverberg MJ, Henschke CI, Justice A, Braithwaite RS, Wisnivesky J, Crothers K. Benefits and harms of lung cancer screening in HIV-infected individuals with CD4+ cell count at least 500 cells/&mgr;l. AIDS 2018, 32: 1333-1342. PMID: 29683843, PMCID: PMC5991188, DOI: 10.1097/qad.0000000000001818.Peer-Reviewed Original ResearchConceptsLow-dose computed tomographyLung cancer screeningCD4 cell countMedicaid Services criteriaCancer screeningLung cancerMortality reductionCell countLDCT examinationsAnnual low-dose computed tomographyUninfected individualsLung cancer mortality reductionVeterans Aging Cohort StudyCancer mortality reductionAntiretroviral therapy adherenceAging Cohort StudyLung cancer mortalityCells/Lung Cancer Policy ModelMultiple national organizationsAlternative screening strategiesBase-case analysisHIV cohortCohort studyFormer smokers
2011
Cancer Screening in Patients Infected with HIV
Sigel K, Dubrow R, Silverberg M, Crothers K, Braithwaite S, Justice A. Cancer Screening in Patients Infected with HIV. Current HIV/AIDS Reports 2011, 8: 142-152. PMID: 21695529, PMCID: PMC3307131, DOI: 10.1007/s11904-011-0085-5.Peer-Reviewed Original ResearchConceptsCancer screening interventionsCancer screeningScreening interventionsGeneral populationHIV clinical practiceAnal cancerHodgkin's lymphomaLung cancerHepatocellular carcinomaHIVClinical practicePatientsEnhanced riskScreening testHealth maintenanceSpecific cancersCancerHealth concernLife expectancyGood evidenceParticular cancerLymphomaRiskScreeningIntervention
2007
A Framework for Tailoring Clinical Guidelines to Comorbidity at the Point of Care
Braithwaite RS, Concato J, Chang CC, Roberts MS, Justice AC. A Framework for Tailoring Clinical Guidelines to Comorbidity at the Point of Care. JAMA Internal Medicine 2007, 167: 2361-2365. PMID: 18039996, PMCID: PMC3460384, DOI: 10.1001/archinte.167.21.2361.Peer-Reviewed Original ResearchConceptsCongestive heart failureHuman immunodeficiency virusComorbidity-adjusted life expectancyColorectal cancer screeningColorectal cancerClinical guidelinesCancer screeningLife expectancyHeart failureComorbidity profilesImmunodeficiency virusPoint of careIndividual patientsPatientsIncremental benefitCancerComorbiditiesWomenMenGuidelinesExpectancyPayoff timeScreeningYearsCare